Hood River Capital Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-791,324
Closed -$27.3M 142
2023
Q1
$27.3M Buy
791,324
+31,909
+4% +$1.04M 0.88% 47
2022
Q4
$21.2M Buy
759,415
+72,954
+11% +$1.93M 0.77% 52
2022
Q3
$16.1M Buy
686,461
+12,878
+2% +$411K 0.61% 56
2022
Q2
$19.5M Buy
673,583
+29,394
+5% +$1.28M 0.77% 52
2022
Q1
$35.5M Buy
644,189
+94,596
+17% +$4.68M 1.18% 30
2021
Q4
$29.4M Buy
549,593
+126,105
+30% +$5.85M 0.88% 44
2021
Q3
$17.9M Sell
423,488
-17,551
-4% -$896K 0.55% 64
2021
Q2
$29.4M Buy
441,039
+253,101
+135% +$13.7M 0.87% 45
2021
Q1
$8.32M Buy
+187,938
New +$6.98M 0.27% 95

Other funds holding SGRY

Hood River Capital Management's SGRY Position: Q2 2023 in Review

Hood River Capital Management sold out of Surgery Partners (SGRY) in Q2 2023, closing a stake of 791,324 shares — an estimated $27.3M sold.

Hood River Capital Management first reported a position in SGRY in Q1 2021 and held it in 9 quarters. The position peaked at $35.5M in Q1 2022. 168 funds tracked by Wall St. Rank hold SGRY as of Q2 2023.

  • Hood River Capital Management reported no remaining Surgery Partners position as of Q2 2023 after selling out during the quarter.
  • Hood River Capital Management sold 791,324 Surgery Partners shares in Q2 2023, an estimated $27.3M.
  • Hood River Capital Management first reported a position in Surgery Partners in Q1 2021 and held it in 9 quarters.
  • Hood River Capital Management's Surgery Partners position peaked at $35.5M in Q1 2022.
  • 168 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2023.

Based on Hood River Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.